{"pmid":32329517,"title":"COVID-19 diffusion capability is its worst, unpredictable chracateristic. How to visit a patient from a distance.","text":["COVID-19 diffusion capability is its worst, unpredictable chracateristic. How to visit a patient from a distance.","Br J Surg","Sterpetti, A V","32329517"],"journal":"Br J Surg","authors":["Sterpetti, A V"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32329517","week":"202017|Apr 20 - Apr 26","doi":"10.1002/bjs.11644","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664996914869829632,"score":8.518259,"similar":[{"pmid":32282870,"pmcid":"PMC7161307","title":"COVID-19: The Worst Days of Our Careers.","text":["COVID-19: The Worst Days of Our Careers.","Ann Intern Med","Cunningham, Chinazo O","Diaz, Chanelle","Slawek, Deepika E","32282870"],"journal":"Ann Intern Med","authors":["Cunningham, Chinazo O","Diaz, Chanelle","Slawek, Deepika E"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282870","week":"202016|Apr 13 - Apr 19","doi":"10.7326/M20-1715","source":"PubMed","topics":["General Info"],"weight":1,"_version_":1664636703968591872,"score":68.60953},{"pmid":32302395,"title":"Rapid Development of Telehealth Capabilities within Pediatric Patient Portal Infrastructure for COVID-19 Care: Barriers, Solutions, Results.","text":["Rapid Development of Telehealth Capabilities within Pediatric Patient Portal Infrastructure for COVID-19 Care: Barriers, Solutions, Results.","The COVID-19 national emergency has led to surging care demand and the need for unprecedented telehealth expansion. Rapid telehealth expansion can be especially complex for pediatric patients. From the experience of a large academic medical center, this report describes a pathway for efficiently increasing capacity of remote pediatric enrollment for telehealth while fulfilling privacy, security, and convenience concerns. The design and implementation of the process took two days. Weekly enrollment subsequently increased 10-fold for children (age 0-12 years) and 1.2-fold for adolescents (age 13-17 years). Weekly telehealth visits increased 200-fold for children and 90-fold for adolescents. The obstacles and solutions presented in this report can provide guidance to health systems for similar challenges during the COVID-19 response and future disasters.","J Am Med Inform Assoc","Patel, Pious D","Cobb, Jared","Wright, Deidre","Turer, Rob","Jordan, Tiffany","Humphrey, Amber","Kepner, Adrienne L","Smith, Gaye","Rosenbloom, S Trent","32302395"],"abstract":["The COVID-19 national emergency has led to surging care demand and the need for unprecedented telehealth expansion. Rapid telehealth expansion can be especially complex for pediatric patients. From the experience of a large academic medical center, this report describes a pathway for efficiently increasing capacity of remote pediatric enrollment for telehealth while fulfilling privacy, security, and convenience concerns. The design and implementation of the process took two days. Weekly enrollment subsequently increased 10-fold for children (age 0-12 years) and 1.2-fold for adolescents (age 13-17 years). Weekly telehealth visits increased 200-fold for children and 90-fold for adolescents. The obstacles and solutions presented in this report can provide guidance to health systems for similar challenges during the COVID-19 response and future disasters."],"journal":"J Am Med Inform Assoc","authors":["Patel, Pious D","Cobb, Jared","Wright, Deidre","Turer, Rob","Jordan, Tiffany","Humphrey, Amber","Kepner, Adrienne L","Smith, Gaye","Rosenbloom, S Trent"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32302395","week":"202016|Apr 13 - Apr 19","doi":"10.1093/jamia/ocaa065","keywords":["covid-19","consumer health informatics","patient portals","policy","sars-cov-2","telehealth"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664635401407561728,"score":49.554485},{"pmid":32253251,"title":"Lessons from covid-19: visiting patients at home and assessing comorbidities.","text":["Lessons from covid-19: visiting patients at home and assessing comorbidities.","BMJ","Stevens, Anna M H","32253251"],"journal":"BMJ","authors":["Stevens, Anna M H"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32253251","week":"202015|Apr 06 - Apr 12","doi":"10.1136/bmj.m1385","link_comment_for":"32184276","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664640769784283137,"score":46.787},{"pmid":32199943,"title":"Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2.","text":["Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2.","SARS-CoV-2, the newly identified human coronavirus causing severe pneumonia pandemic, was probably originated from Chinese horseshoe bats. However, direct transmission of the virus from bats to humans is unlikely due to lack of direct contact, implying the existence of unknown intermediate hosts. Angiotensin converting enzyme 2 (ACE2) is the receptor of SARS-CoV-2, but only ACE2s of certain species can be utilized by SARS-CoV-2. Here, we evaluated and ranked the receptor-utilizing capability of ACE2s from various species by phylogenetic clustering and sequence alignment with the currently known ACE2s utilized by SARS-CoV-2. As a result, we predicted that SARS-CoV-2 tends to utilize ACE2s of various mammals, except murines, and some birds, such as pigeon. This prediction may help to screen the intermediate hosts of SARS-CoV-2.","Microbes Infect","Qiu, Ye","Zhao, Yuan-Bo","Wang, Qiong","Li, Jin-Yan","Zhou, Zhi-Jian","Liao, Ce-Heng","Ge, Xing-Yi","32199943"],"abstract":["SARS-CoV-2, the newly identified human coronavirus causing severe pneumonia pandemic, was probably originated from Chinese horseshoe bats. However, direct transmission of the virus from bats to humans is unlikely due to lack of direct contact, implying the existence of unknown intermediate hosts. Angiotensin converting enzyme 2 (ACE2) is the receptor of SARS-CoV-2, but only ACE2s of certain species can be utilized by SARS-CoV-2. Here, we evaluated and ranked the receptor-utilizing capability of ACE2s from various species by phylogenetic clustering and sequence alignment with the currently known ACE2s utilized by SARS-CoV-2. As a result, we predicted that SARS-CoV-2 tends to utilize ACE2s of various mammals, except murines, and some birds, such as pigeon. This prediction may help to screen the intermediate hosts of SARS-CoV-2."],"journal":"Microbes Infect","authors":["Qiu, Ye","Zhao, Yuan-Bo","Wang, Qiong","Li, Jin-Yan","Zhou, Zhi-Jian","Liao, Ce-Heng","Ge, Xing-Yi"],"date":"2020-03-23T11:00:00Z","year":2020,"_id":"32199943","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.micinf.2020.03.003","keywords":["Angiotensin converting enzyme 2 (ACE2)","Coronavirus","Phylogenetic analysis","Receptor utilization","SARS-CoV-2"],"source":"PubMed","locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Mechanism","Transmission"],"weight":1,"_version_":1663352133614829569,"score":46.2021},{"pmid":32297458,"title":"How to Conduct an Outpatient Telemedicine Rehabilitation or Prehabilitation Visit.","text":["How to Conduct an Outpatient Telemedicine Rehabilitation or Prehabilitation Visit.","The novel coronavirus pandemic is resulting in an accelerated conversion of in-person physician visits to virtual visits. As barriers to adoption of telemedicine are rapidly decreasing, it is important to recognize the need for practical and immediately deployable information that can improve doctor-patient interactions, facilitate accurate documentation, and increase confidence in the transition to virtual visits. In this article we aim to outline the components of an outpatient telemedicine visit for physiatrists with a particular focus on an adapted virtual physical examination. Uses of telemedicine may include future largescale concerns such as natural disasters or climate change. We describe a general approach to the visit, review definitions of terms commonly used in telemedicine, and offer tips for optimizing the encounter. This article is protected by copyright. All rights reserved.","PM R","Verduzco-Gutierrez, Monica","Bean, Allison C","Tenforde, Adam S","Tapia, Rebecca N","Silver, Julie K","32297458"],"abstract":["The novel coronavirus pandemic is resulting in an accelerated conversion of in-person physician visits to virtual visits. As barriers to adoption of telemedicine are rapidly decreasing, it is important to recognize the need for practical and immediately deployable information that can improve doctor-patient interactions, facilitate accurate documentation, and increase confidence in the transition to virtual visits. In this article we aim to outline the components of an outpatient telemedicine visit for physiatrists with a particular focus on an adapted virtual physical examination. Uses of telemedicine may include future largescale concerns such as natural disasters or climate change. We describe a general approach to the visit, review definitions of terms commonly used in telemedicine, and offer tips for optimizing the encounter. This article is protected by copyright. All rights reserved."],"journal":"PM R","authors":["Verduzco-Gutierrez, Monica","Bean, Allison C","Tenforde, Adam S","Tapia, Rebecca N","Silver, Julie K"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297458","week":"202016|Apr 13 - Apr 19","doi":"10.1002/pmrj.12380","keywords":["telemedicine","rehabilitation","telehealth","virtual visit"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1664641388442025984,"score":43.72866}]}